Cost-effectiveness analysis of commercial Chinese polyherbal preparations for primary insomnia: based on network meta-analysis

Within the 60-day time horizon of this analysis, TM + BZDs demonstrated optimal cost-effectiveness for primary insomnia from a healthcare system perspective, followed by WL and BLM. Limitations in data sources constrain the generalizability of findings. Future studies adopt a societal perspective and incorporate individual-level data over longer time horizons to validate and extend current results through more comprehensive cost-utility evaluations. Furthermore, research should focus on Traditional Chinese medicine (TCM)-specific health utility scales and informing equity-focused reimbursement policies to fully capture the value of CCPPs, thereby ultimately optimizing healthcare access and resource allocation.